SCHEMBL7797586

SCHEMBL7797586

CCOC(=O)C(CC(=O)c1ccc(Cl)c(Cl)c1)(NC=O)C(=O)OCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.45
MAPK1 P28482 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TSHR P16473 2/20 0.42
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.40
KMO O15229 2/20 0.39
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC9 Q9UKV0 2/20 0.39
HDAC5 Q9UQL6 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8657896 0.94 MAPT (0.43) MAPTMAPK1NPSR1TSHRLMNA
SCHEMBL7799547 0.86 SMN1; SMN2 (0.45) MAPTMAPK1NPSR1TSHRLMNA
SCHEMBL7800768 0.84 MAPT (0.44) MAPTNPSR1LMNASMN1; SMN2ALDH1A1
SCHEMBL7799501 0.84 ALDH1A1 (0.49) MAPTMAPK1NPSR1TSHRLMNA
SCHEMBL7797583 0.83 ALDH1A1 (0.43) MAPTNPSR1TSHRALDH1A1HPGD
SCHEMBL7797567 0.82 ALDH1A1 (0.47) MAPTMAPK1TSHRLMNASMN1; SMN2
SCHEMBL7797580 0.82 ERCC5 (0.43) MAPTTSHRLMNAKDM4EALDH1A1
SCHEMBL7800771 0.81 NPSR1 (0.42) MAPTNPSR1LMNASMN1; SMN2HDAC8
SCHEMBL7800741 0.81 ALDH1A1 (0.44) MAPTMAPK1NPSR1LMNASMN1; SMN2
SCHEMBL7799487 0.81 ALDH1A1 (0.49) MAPTMAPK1NPSR1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES VARASI MARIO (IT) 2001-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES KYNU, KMO, ABAT MAPT 206/4885MAPK1 2502/4885NPSR1 2884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.